HUPO 2011: The New Cardiovascular Initiative - Integrating Proteomics and Cardiovascular Biology in Health and Disease

Authors

  • Maggie P. Y. Lam,

    1. Departments of Physiology and Medicine, Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Search for more papers by this author
  • Fernando Vivanco,

    1. Department of Immunology, Fundacion Jimenez Diaz, Madrid, and Department of Biochemistry and Molecular Biology I, Universidad Complutense de Madrid, Spain
    Search for more papers by this author
  • Arjen Scholten,

    1. Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences,, Utrecht University, Utrecht, The Netherlands
    Search for more papers by this author
  • Henning Hermjakob,

    1. European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge, UK
    Search for more papers by this author
  • Jennifer Van Eyk,

    1. Johns Hopkins Bayview Proteomics Center, Department of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA
    Search for more papers by this author
  • Peipei Ping

    1. Departments of Physiology and Medicine, Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Search for more papers by this author

Abstract

A newly reorganized HUPO Cardiovascular Initiative was announced at the HUPO 2011 Cardiovascular Initiative Workshop at Geneva. The new initiative is now part of the biology- and disease-driven component of the HUPO Human Proteome Project (B/D-HPP). Here we report the recent achievements and future directions of the initiative, and offer a perspective on the present challenges of cardiovascular proteomics and its integration with the cardiovascular biology community at large.

Ancillary